Clinical pathology

MLS teams win bowling competition

Tweet tweet button for twitter Posted on May 27, 2021 University of Louisiana Monroe Medical Laboratory Science students competed and won a virtual bowl competition against the University of Arkansas for MLS Medical Science students. University of Louisiana Monroe MLS students from the School of Allied Health, College of Health …

Read More »

Moderna COVID-19 vaccine has been shown to be effective for adolescents; those recovering from mild illness get antibody protection: May 26, 2021 coronavirus update

CLEVELAND, Ohio – Moderna’s COVID-19 vaccine is effective in young adolescents, and mild cases of COVID-19 give those recovering from the disease long-lasting antibody protection. Cleveland.com brings together some of the most notable coronavirus news that is making headlines online. Here’s what you need to know for Wednesday, May 26th. …

Read More »

Cyclerion Therapeutics splits up – GuruFocus.com

CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) – Cyclerion Therapeutics, Inc. (CYCN) today announced that company management will present an overview of the company at the Jefferies Virtual Healthcare conference on Tuesday, 1 June 2021 at 4:00 p.m. pm ET. Management will also be available for one-on-one meetings and investors …

Read More »

Professional nurse: clinical trials / 1 year FTC / CLS

A Professional Nurse – Clinical Trials position (one year contract) is available with our client, Clinical Laboratory Services (CLS) of the Wits Health Consortium in Braamfontein, Johannesburg – Gauteng. Background Clinical Laboratory Services (CLS) is a division of the Wits Health Consortium (WHC) of the School of Pathology. The main …

Read More »

Ferring and Rebiotix Present Flagship Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Compared to Placebo in Reducing Recurrence of C. difficile Infection

SAINT-PREX, Switzerland & ROSEVILLE, Minnesota – (BUSINESS WIRE) – Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented the results of the pivotal phase 3 PUNCH ™ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) compared to placebo. …

Read More »